DENTSPLY SIRONA Inc. (XRAY) Stock

DENTSPLY SIRONA Inc. (XRAY) is a Healthcare stock trading at $10.78 (as of 2026-08-20), with a market capitalization of $2.16B. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

DENTSPLY SIRONA manufactures and sells dental products and technologies for the professional dental market worldwide, including dental equipment, digital CAD/CAM and related technologies, clear aligner solutions, implants, and healthcare consumables. It also offers consumable categories such as endodontic tools and restorative products, organized in the Technologies & Equipment and Consumables segments.

Understand DENTSPLY SIRONA Inc.: how it makes money

DENTSPLY SIRONA manufactures and sells dental products and technologies for the professional dental market worldwide, including dental equipment and technologies as well as consumables, and it generates revenue from sales of these product lines through its two reportable segments.

Its profit model is driven by the scale and mix of revenue from two segment lines, Consumables and Technologies & Equipment.

Business quality (Weak): Latest period shows a high gross margin (48.5%) alongside a negative operating margin (-4.0%), which suggests operating costs, investments, or mix pressures are currently outweighing gross profit generation.

Bull case

  • Strong gross profitability: In the latest period, gross margin was 48.5%, indicating products generate meaningful gross profit before operating expenses.
  • Segmented business lines: The company reports two segment lines, Consumables and Technologies & Equipment, which provides multiple sources of revenue within its dental offering.

Bear case

  • Negative operating margin: The latest period operating margin was -4.0%, meaning operating income was negative despite positive gross margin.
  • Revenue concentration by geography is notable: The company breaks out revenue by regions such as Europe, the United States, and Rest of World, which can expose results to regional demand and commercial conditions.
Valuation — source: SEC EDGAR (first-party)
Price$10.78
Market Cap$2.16B
EV / EBITDA210.2
Price / Book1.64
Price / Sales0.60
FCF Yield1.1%
DCF Value (model)$13.95
DCF Upside vs Price29.5%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$3.68B
Net Margin-16.3%
Revenue Growth (YoY)-3.0%
EPS Growth (YoY)-33.0%
FCF Growth (YoY)-63.0%
Financial Health — source: SEC EDGAR
Altman Z-Score0.48 (distress)
Piotroski F-Score5/9 (moderate)
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.6
Industry P/E (Medical Equipment)32.9
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD GROUP INC ($249.87M)
Institutional Holders Tracked10
Congressional Trades (recent)3
Company
SectorHealthcare
IndustryMedical Equipment
CEODaniel T. Scavilla
Employees14,000
CountryUS
IPO Date1987-08-12

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Envista Holdings Corp (NVST)
  • TransMedics Group, Inc. (TMDX)
  • AxoGen, Inc. (AXGN)
  • AtriCure, Inc. (ATRC)
  • Butterfly Network, Inc. (BFLY)
  • UFP Technologies, Inc. (UFPT)
  • LeMaitre Vascular, Inc. (LMAT)
  • BioLife Solutions, Inc. (BLFS)
XRAY earnings history · XRAY institutional & insider holders · XRAY KPIs & operating metrics · XRAY financials · XRAY investor presentations & press releases · XRAY SEC filings · XRAY peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-20.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.